FDA Extends Comment Period on Medical User Fee Program
The Food and Drug Administration is extending to November 1, 2010, the comment period for the notice that appeared in the August 13, 2010 Federal Register, in which FDA requested input and comments from interested stakeholders on FDA’s medical user…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program.